Smoking in Pregnancy Linked to Risk of Schizophrenia Diagnosis in Later Life
In the first study of its kind, researchers from Finland found the âmost definitive evidence to dateâ that smoking during pregnancy is associated with the eventual diagnosis of schizophrenia in offspring. After controlling for other potential variables, the study, published ahead of print in The American Journal of Psychiatry, revealed a 38% increased odds of developing symptoms diagnosed as schizophrenia in young adults who were exposed to high levels of nicotine in utero.
Correction: No “Charges” Against Former FDA Commissioner Margaret Hamburg
Our headline on an Around the Web item posted on June 8Â stating that the former head of the FDA, Margaret Hamburg, had been "charged"...
Study Finds Racial and Class Discrimination in Psychotherapy
Are psychotherapists less likely to accept patients that are working class or black? According to a new study from the American Sociological Association, the answer is yes. The study, published in this monthâs issue of the Journal of Health and Social Behavior, found that therapists in New York City were less likely to offer appointments to patients who were black or lower working-class.
âTasty and Easy to Take, A New ADHD Drug Alarms Some Psychiatrists”
For STAT, Meghana Kashavan reports on a new, candy-flavored, chewable, fruity, amphetamine drug on the market for children diagnosed with ADHD. âItâs a move...
âContext Matters When Replicating Experiments, Argues Studyâ
Retraction Watch reports on a new study suggesting that research experiments that are âcontextually sensitive,â like many of those in psychology and the social...
Undisclosed Financial Conflicts Endemic in Clinical Practice Guidelines
While there has been a recent push to account for financial conflicts of interest in medical research, less attention has been paid to organizations...
Despite Official Recommendations, Young Children Are Still Receiving Drugs Instead of Therapy for âADHDâ
In 2011 the American Academy of Pediatrics (AAP) issued guidelines recommending therapy over stimulant drugs as the primary treatment for children diagnosed with âADHD.â New research from the CDC reveals, however, that children between ages 2 and 5 are still being prescribed medications before receiving the recommended therapy or psychological services. Overall, the researchers found that 75% of these children are being prescribed âADHDâ drugs while no more than 55% receive psychological treatments. Incredibly, among children on private insurances, the percentage of children receiving psychological services for âADHDâ showed no increase following the 2011 recommendations.
Moving Forward in the Science of Psychiatric Medication Discontinuation/Reduction
This week Live & Learn launched a research study on the experience of people labeled with mental disorders who have tried to stop taking psychiatric medications. This project -- the Psychiatric Medication Discontinuation/Reduction (PMDR) Study -- aims to understand the process of coming off psychiatric medications in order to better support those who choose to do so. The study seeks to answer the question: What helps people stop their psychiatric medications? What gets in the way of stopping?
Researcher Urges Caution When Applying Genetics to Psychiatry
In a review editorial for the journal Psychotherapy and Psychosomatics, neurobiology researcher Steven Dubovsky from the University at Buffalo argues against the adoption of...
Illness Inflation: Expanded Medical Definitions Create More Patients
The Milwaukee Journal Sentinel has issued a watchdog report titled âIllness Inflationâ that examines how new medical conditions are often the product of industry...
âBayer and Monsanto: A Marriage Made in Hellâ
For CounterPunch, Martha Rosenberg and Ronnie Cummins comment on the announcement that Bayer has placed a bid to buy Monsanto. âBayer and Monsanto both...
âLawmakers Accuse HHS of Delaying FDA Guidelines for Off-Label Marketingâ
Ed Silverman reports for STATâs Pharmalot that high-ranking congressmen are accusing the Department of Health and Human Services of deliberately delaying new guidelines on...
âFeds Probe Drugmaker-Charity Connectionsâ
Last week, reports circulated about a system through which drug companies used charitable giving for profit. Now, three drug manufacturers, Gilead Sciences Inc., Biogen...
Does Your Child Have âADHDâ? It Might Depend On Your Doctor
A study published in the journal Pediatrics reveals large differences from one pediatrician to the next when it comes to diagnosing and prescribing drugs for âADHD.â The researchers found that the percentage of children being diagnosed with âADHDâ varied from as high as 16% of patients at some offices to as little as 1% of patients at others. The data also revealed significant but lower variability in the pediatric diagnosis of anxiety and depression.
Rising Prescriptions, Rising Disability: Video from the UK Parliament
Mental health campaigner Chrys Muirheadâs blog features video from the All-Party Parliamentary Group for Prescribed Drug Dependence event on 11 May 2016 at Westminster....
ââDisease AwarenessââHow Big Pharma Preps You to Buy Drugs You Probably Don’t Need”
The latest from Martha Rosenberg: âPharma companies love disease awareness advertising because, unlike direct-to-consumer (DTC) advertising, risks and warnings of possible drug treatments do...
Are DNA Changes the Link Between Poverty and Mental Illness?
Researchers at Duke University who studied 183 adolescents for three years found that increased depression associated with poverty may be mediated by epigenetic changes in DNA. The...
Mindfulness Therapy May Be More Effective Without Antidepressants
While an estimated 74-percent of patients diagnosed with major depression receive a prescription for an antidepressant, new research reveals that mindfulness-based cognitive therapy (MBCT)...
âFrance Tightens Rules in Wake of Fatal Clinical Trial Disasterâ
After a clinical trial killed one person and landed five others in intensive care, the government is demanding that the clinical trial company responsible, Biotrial,...
Study Finds Racial Differences in Psychiatric Diagnosis and Treatment
Black patients are almost twice as likely as their white counterparts to be diagnosed with schizophrenia while whites are significantly more likely to receive a diagnosis of anxiety or depression, according to a recent study published in the journal Psychiatric Services. The researchers also found that the likelihood of receiving psychotherapy for any diagnosis (34%), regardless of race or ethnicity, was much lower than the likelihood of receiving a psychotropic medication (73%).
âThe Hidden Harms of Antidepressantsâ
In a new article for Scientific American, Diana Kwon reports on how the true risks for suicide and aggression in children and teens taking...
Mental Health Treatments Top List of US Healthcare Spending
According to new research, the United States spends over 200 billion annually on treatment and hospitalization for mental health issues, exceeding spending on heart...
âIs Depression an Illness? Or Part of the Human Condition?â
Psychotherapist Chantal Marie Gagnon voices her frustration with social media posts and stigma reduction ads that perpetuate the belief that all mental health issues...
Antidepressants Not a âOne Size Fits Allâ Solution, Researchers Find
The largest ever study of the thoughts and reactions of antidepressant users reveals that many people have vastly different understandings and experiences of the...
âPsychiatric Drugs Killing More Users than Heroin, Cocaine, Say Health Expertsâ
A groundbreaking article for The Province is âsounding the alarm over the heightened risk of death linked to the use of psychiatric drugs.â They report on...